| Primary |
| Hiv Infection |
75.7% |
| Antiretroviral Therapy |
5.9% |
| Hiv Test Positive |
3.6% |
| Acquired Immunodeficiency Syndrome |
2.5% |
| Hypertension |
1.5% |
| Infection |
1.1% |
| Prophylaxis Against Hiv Infection |
1.1% |
| Pain |
1.0% |
| Tuberculosis |
1.0% |
| Depression |
0.8% |
| Hepatitis C |
0.8% |
| Hyperlipidaemia |
0.8% |
| Prophylaxis |
0.8% |
| Viral Infection |
0.8% |
| Diabetes Mellitus |
0.6% |
| Haemarthrosis |
0.6% |
| Arthralgia |
0.4% |
| Blastomycosis |
0.4% |
| Hepatitis B Virus Test |
0.4% |
| Herpes Simplex |
0.4% |
|
| Portal Hypertension |
8.8% |
| Pregnancy |
8.8% |
| Eyelid Ptosis |
6.9% |
| Varices Oesophageal |
6.9% |
| Weight Decreased |
6.9% |
| Pulmonary Hypertension |
5.9% |
| Vomiting |
5.9% |
| Facial Wasting |
4.9% |
| Pancreatitis |
4.9% |
| Stillbirth |
4.9% |
| Lipodystrophy Acquired |
3.9% |
| Pancreatic Mass |
3.9% |
| Renal Tubular Disorder |
3.9% |
| Retinal Detachment |
3.9% |
| Umbilical Hernia |
3.9% |
| Ventricular Septal Defect |
3.9% |
| Impaired Work Ability |
2.9% |
| Myocardial Infarction |
2.9% |
| Osteonecrosis |
2.9% |
| Palpitations |
2.9% |
|
| Secondary |
| Hiv Infection |
76.9% |
| Drug Use For Unknown Indication |
4.7% |
| Acquired Immunodeficiency Syndrome |
3.6% |
| Product Used For Unknown Indication |
2.4% |
| Antiretroviral Therapy |
2.1% |
| Drug Exposure During Pregnancy |
1.6% |
| Hepatitis C |
1.1% |
| Antiviral Treatment |
1.0% |
| Human Immunodeficiency Virus Transmission |
1.0% |
| Factor Viii Deficiency |
1.0% |
| Antiviral Prophylaxis |
0.6% |
| Hiv Test Positive |
0.6% |
| Depression |
0.6% |
| Liver Disorder |
0.6% |
| Prophylaxis |
0.5% |
| Hypertension |
0.4% |
| Weight Decreased |
0.4% |
| Diarrhoea |
0.4% |
| Castleman's Disease |
0.3% |
| Pain |
0.3% |
|
| Weight Decreased |
12.6% |
| Renal Failure Acute |
7.6% |
| Neutropenia |
7.2% |
| Pulmonary Hypertension |
6.7% |
| Varices Oesophageal |
6.7% |
| Abortion Spontaneous |
4.9% |
| Drug Exposure During Pregnancy |
4.9% |
| Liver Disorder |
4.9% |
| Myositis |
4.5% |
| Pregnancy |
4.5% |
| Stillbirth |
4.0% |
| Transaminases Increased |
4.0% |
| Vomiting |
4.0% |
| Thrombocytopenia |
3.6% |
| Ventricular Septal Defect |
3.6% |
| Vertigo |
3.6% |
| Abortion Induced |
3.1% |
| Lipodystrophy Acquired |
3.1% |
| Myocardial Infarction |
3.1% |
| Osteoporosis |
3.1% |
|
| Concomitant |
| Hiv Infection |
65.9% |
| Product Used For Unknown Indication |
5.3% |
| Drug Use For Unknown Indication |
5.0% |
| Antiretroviral Therapy |
3.9% |
| Drug Exposure During Pregnancy |
2.4% |
| Depression |
1.5% |
| Medical Diet |
1.5% |
| Haemorrhoids |
1.4% |
| Acquired Immunodeficiency Syndrome |
1.3% |
| Hiv Test Positive |
1.3% |
| Hiv Infection Cdc Category B3 |
1.2% |
| Hepatitis C |
1.2% |
| Factor Viii Deficiency |
1.1% |
| Hypertension |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Lung Disorder |
1.1% |
| Antiviral Prophylaxis |
1.0% |
| Exposure During Pregnancy |
1.0% |
| Lower Gastrointestinal Haemorrhage |
0.9% |
| Antiviral Treatment |
0.9% |
|
| Weight Decreased |
13.0% |
| Spinal Compression Fracture |
8.6% |
| Vomiting |
8.0% |
| Disturbance In Attention |
6.8% |
| White Blood Cell Count Decreased |
6.2% |
| Ventricular Extrasystoles |
4.9% |
| Pain In Extremity |
4.3% |
| Pregnancy |
4.3% |
| Transaminases Increased |
4.3% |
| Blood Creatinine Increased |
3.7% |
| Chest Pain |
3.7% |
| Hodgkin's Disease |
3.7% |
| Optic Neuritis Retrobulbar |
3.7% |
| Overdose |
3.7% |
| Pyrexia |
3.7% |
| Renal Failure |
3.7% |
| Renal Failure Acute |
3.7% |
| Vertigo |
3.7% |
| Nephrolithiasis |
3.1% |
| Thrombotic Thrombocytopenic Purpura |
3.1% |
|
| Interacting |
| Hiv Infection |
39.4% |
| Drug Use For Unknown Indication |
19.7% |
| Hypertension |
14.1% |
| Product Used For Unknown Indication |
14.1% |
| Hyperphosphataemia |
8.5% |
| Renal Failure |
2.8% |
| Nephropathy |
1.4% |
|
| Drug Interaction |
28.6% |
| Unevaluable Event |
21.4% |
| Lipodystrophy Acquired |
14.3% |
| Pancreatitis Acute |
14.3% |
| Mitochondrial Cytopathy |
7.1% |
| Visual Acuity Reduced |
7.1% |
| Vomiting |
7.1% |
|
